ABBV
AbbVie Inc.
AbbVie Inc. (ABBV) has 16 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: May 12, 2026.
Insiders have net sold $10.7M over the trailing 6 months.
- Industry:Drug Manufacturers - General
- CEO:Robert A. Michael
- Employees:57,000
- HQ:North Chicago, IL, US
- IPO:2013-01-02
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$10.7M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$454.8B
latest known value
Earnings: last 7 quarters
EstimatedActual
| Source | ||||||
|---|---|---|---|---|---|---|
Purdue David RyanFirst filing | SVP, Controller | Sale | 5,230 | $1.2M | Mar 6 | SEC ↗ |
| EVP, GC AND SECRETARY | Sale | 18,668 | $4.4M | Mar 3 | SEC ↗ | |
Siatis Perry CFirst filing | EVP, GC AND SECRETARY | Sale | 22,381 | $5.1M | Feb 27 | SEC ↗ |
Congress trading ABBV
See timeline →- DRep. Ro KhannaPurchase$15,001 - $50,0002026-05-01
- DRep. Josh GottheimerSale$1,001 - $15,0002026-05-05
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
AbbVie Inc. is in the Healthcare sector.